搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
PharmaTimes
5 小时
Network of trust
Distributing reliable information about medicines is challenging for the pharma industry and the healthcare professionals ...
PharmaTimes
6 小时
Research resolutions
UK research regulatory bodies – the Health Research Authority (HRA) and the Medicines and Healthcare products Regulatory Agency (MHRA) – are developing a set of questions and supporting guidance that ...
PharmaTimes
1 天
Abstract smart
Imperative for AI-powered productivity enhancement ...
PharmaTimes
1 天
Healthcare balancing act
The revelation by the record-breaking Olympic cyclist Sir Chris Hoy that he has an untreatable form of prostate cancer, was a ...
PharmaTimes
1 天
No patient left behind
Yet only 5% have an approved therapy, and none offers a cure, leaving a significant unmet medical need. Due to the limited ...
PharmaTimes
1 天
Design for life
The need to get digital products to market quickly is a common problem among teams in the pharma industry.
PharmaTimes
1 天
Test of trust
The pharmaceutical industry stands at a crucial juncture, poised to be reshaped by transformative technology advancement.
PharmaTimes
1 天
Paula Sutherland
Alliance Healthcare UK has announced that Paula Sutherland has been appointed to the position of Sales Director. Paula will ...
PharmaTimes
1 天
Janine Schuurman
Commit Biologics has announced the appointment of Janine Schuurman to its Board of Directors. Janine is a widely recognised ...
PharmaTimes
2 天
PharmaTimes - January/February 2025
The great table of debate has been pulled up, as argument and counter argument wrestle for supremacy in the first tubthumping ...
PharmaTimes
2 天
Cartesian Therapeutics announces FDA agreement for new trial
Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol ...
PharmaTimes
2 天
FDA approves new Alzheimer’s treatment regimen
The US Food and Drug Administration (FDA) has approved Eisai and Biogen’s Supplemental Biologics License Application for once ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈